Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Sep;146(3):195-200.
doi: 10.1085/jgp.201511479.

Sphingomyelin, ORAI1 channels, and cellular Ca2+ signaling

Patrick G Hogan  1
Affiliations
Comment

Sphingomyelin, ORAI1 channels, and cellular Ca2+ signaling

Patrick G Hogan. J Gen Physiol. 2015 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Some sphingolipid fundamentals. (A) Depictions of sphingomyelin and ceramide. The bonds cleaved by SMase C and SMase D are indicated. (B) De novo synthesis of sphingomyelin. The first four enzymatic steps of the de novo pathway take place at the cytoplasmic face of the ER, the last step at the cytoplasmic face of the Golgi complex. Breakdown of cellular sphingomyelin and resynthesis of sphingomyelin from ceramide also occur at other locations in the cell. Separate branches of the de novo synthetic pathway (not depicted) lead from ceramide to the two major classes of glycosphingolipids. (C) Sphingomyelin metabolism. Mammalian cellular enzymes are able to catalyze all the steps indicated, except the conversion of sphingomyelin to ceramide-1-phosphate. Specific SMase D enzymes that catalyze this step have been isolated from C. pseudotuberculosis and from spider venoms. The spider SMase D product is ceramide 1,3-cyclic phosphate rather than ceramide-1-phosphate (Lajoie et al., 2013), adding a further nuance, since it is not clear whether the cyclic phosphate is readily metabolized by mammalian cellular enzymes. Although the mapped metabolic pathways provide guidance, it is still necessary to determine the actual extent and pattern of sphingomyelin metabolism for any specific cell type, localization in the cell, and experimental condition. CERK, ceramide kinase; LPP, lipid phosphate phosphatase; S1P phosphatase, sphingosine-1-phosphate phosphatase; S1P lyase, sphingosine-1-phosphate lyase. See Gault et al. (2010) for a complete discussion of sphingolipid synthesis and degradation.
Figure 2.
Figure 2.
Two possible mechanisms. (A) Cartoon of STIM–ORAI interaction at an ER–plasma membrane junction. The ORAI1 channel itself is highlighted in red as the target of SMase D, representing a possible mechanism in which SMase D acts on sphingomyelin tightly bound to the channel. This mechanism would parallel the action of SMase D on K+ channels. (B) In an alternative—or additional—mechanism, SMase D might suppress channel function by altering the lipid microdomain surrounding the channel. The relevant changes could be in a relatively localized lipid microdomain, as portrayed with the red highlight, or could involve the plasma membrane of the entire ER–plasma membrane junction.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Andrieu N., Salvayre R., and Levade T.. 1996. Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur. J. Biochem. 236:738–745. 10.1111/j.1432-1033.1996.00738.x - DOI - PubMed
    1. Baird G.J., and Fontaine M.C.. 2007. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J. Comp. Pathol. 137:179–210. 10.1016/j.jcpa.2007.07.002 - DOI - PubMed
    1. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P., et al. . 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:21453–21457. 10.1074/jbc.C200176200 - DOI - PubMed
    1. Combs D.J., and Lu Z.. 2015. Sphingomyelinase D inhibits store-operated Ca2+ entry in T lymphocytes by suppressing ORAI current. J. Gen. Physiol. 146:161–172. 10.1085/jgp.201511359 - DOI - PMC - PubMed
    1. Combs D.J., Shin H.-G., Xu Y., Ramu Y., and Lu Z.. 2013. Tuning voltage-gated channel activity and cellular excitability with a sphingomyelinase. J. Gen. Physiol. 142:367–380. 10.1085/jgp.201310986 - DOI - PMC - PubMed

Publication types

MeSH terms